France· FR:66320218
ENTYVIO 300 mg, poudre pour solution à diluer pour perfusion
A medicinal product containing védolizumab, registered in France by TAKEDA PHARMA (DANEMARK).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- VÉDOLIZUMAB
- Manufacturer
- TAKEDA PHARMA (DANEMARK)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009586728731 flacon(s) en verre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Védolizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEntyvio 300 mg, poeder voor concentraat voor oplossing voor infusieTakeda Pharma A/S
- FinlandEntyvioTakeda Pharma A/S
- CzechiaENTYVIOTakeda Pharma A/S, Vallensbaek Strand
- SpainENTYVIO 108 MG SOLUCION INYECTABLE EN JERINGA PRECARGADATakeda Pharma A/S
- United KingdomEntyvio 108mg/0.68ml solution for injection pre-filled pensTakeda UK Ltd
- United StatesEntyvioTakeda Pharmaceuticals America, Inc.
- CanadaENTYVIOTAKEDA CANADA INC
- SwitzerlandEntyvio
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Entyvio
- Liechtenstein · Entyvio
- Norway · Entyvio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df60d471-a160-4d3c-bf38-9e45c5438d59 GET /v1/drugs/df60d471-a160-4d3c-bf38-9e45c5438d59?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66320218",
"date_amm": "2014-05-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/14/923",
"substance": "VÉDOLIZUMAB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about védolizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.